AIkido Pharma (NASDAQ:AIKI) Shares Cross Above 200 Day Moving Average of $2.23

AIkido Pharma Inc. (NASDAQ:AIKI)’s share price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $2.23 and traded as high as $3.00. AIkido Pharma shares last traded at $2.93, with a volume of 20,966 shares traded.

AIkido Pharma Price Performance

The firm has a market capitalization of $15.36 million, a PE ratio of -0.76 and a beta of 0.93. The firm’s fifty day moving average is $2.30 and its two-hundred day moving average is $2.23.

Institutional Trading of AIkido Pharma

Institutional investors have recently modified their holdings of the business. Jane Street Group LLC bought a new stake in AIkido Pharma during the 3rd quarter worth approximately $77,000. Dimensional Fund Advisors LP increased its holdings in AIkido Pharma by 26.5% during the 3rd quarter. Dimensional Fund Advisors LP now owns 57,849 shares of the business services provider’s stock worth $396,000 after acquiring an additional 12,111 shares during the period. Two Sigma Investments LP bought a new stake in AIkido Pharma during the 3rd quarter worth approximately $367,000. Finally, Two Sigma Advisers LP increased its holdings in AIkido Pharma by 630.0% during the 3rd quarter. Two Sigma Advisers LP now owns 86,700 shares of the business services provider’s stock worth $593,000 after acquiring an additional 74,824 shares during the period. 10.88% of the stock is currently owned by hedge funds and other institutional investors.

AIkido Pharma Company Profile

AIkido Pharma Inc, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.